MDT - Abbott Labs Makes Marketing Push For New Glucose Monitors Targets Health-Conscious Consumers | Benzinga
Abbott Laboratories (NYSE:ABT) CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device.
This device targets consumers without diabetes, aiming to personalize health data and enhance understanding of their health metrics.
Also Read: Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits.
Ford projected that Lingo could become a multi-billion-dollar product, although it is still in its nascent stage.
Lingo, an over-the-counter device, is scheduled to launch this year alongside Libre Rio, which received FDA clearance last month.
Abbott’s consumer biowearable, Lingo, is designed for consumers 18 years and older looking to improve their ...